David Littler, the UK General Manager at enChoice UK, discusses how AI-powered search is transforming content repositories within organisations, thereby improving user access to information.
Real-world use of the Moderna and Pfizer vaccines in the United States reveals that both are working at 90% efficacy - with data pointing to one dose being capable of 80% protection.
Adrian Crawley, VP of Synack’s EMEA region, looks at the challenges ‘green’ measures place on cybersecurity protections, vehicle safety, data, city planning, personal information and payments and how a collaborative approach is needed to overcome them.
Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.
In an investigation of over seven million pupils, researchers found that Black pupils have the highest rate of autism in the UK - they further noticed that there is "little research" on the existence of autism in ethnic minorities.
We spoke with Professor Colin Jones, project coordinator of CRESCENDO, about the project’s work in predicting global climate change over the coming century.
According to new ONS data, 36% of UK people who are vaccine hesitant have strong side effect fears - while a further 12% fear needles, and 22% think vaccines could impact fertility.
EU leaders today (25 March) decided not to create an export ban for AstraZeneca vaccines made for the UK - but the feud between AstraZeneca and the bloc remains close to the surface of future discussions.
Gwo-shyh Song, Associate Professor at the National Taiwan University and Global Aqua Survey Ltd, walks us through his high-resolution seabed geophysical survey research around offshore areas in Taiwan.
The University of Manchester found that tinnitus could be a COVID-19 symptom - some patients of the virus are reporting a loss in hearing and ringing of the ears.
Logan Finucan, Access Partnership, explains how the European Commission has launched the process towards the adoption of two adequacy decisions for personal dataflows to the UK.
In a study of over 32,000 people, a US trial found the AstraZeneca vaccine was 100% effective against deaths caused by COVID-19 - the vaccine did not show any connection to blood clots.
